PL3638277T3 - Kompozycje i sposoby hamowania beta sekretazy - Google Patents
Kompozycje i sposoby hamowania beta sekretazyInfo
- Publication number
- PL3638277T3 PL3638277T3 PL18816475.0T PL18816475T PL3638277T3 PL 3638277 T3 PL3638277 T3 PL 3638277T3 PL 18816475 T PL18816475 T PL 18816475T PL 3638277 T3 PL3638277 T3 PL 3638277T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- methods
- beta secretase
- secretase inhibition
- inhibition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Confectionery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762520141P | 2017-06-15 | 2017-06-15 | |
| PCT/US2018/037454 WO2018232063A1 (en) | 2017-06-15 | 2018-06-14 | Compositions and methods for beta secretase inhibition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3638277T3 true PL3638277T3 (pl) | 2025-03-10 |
Family
ID=64655980
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18816475.0T PL3638277T3 (pl) | 2017-06-15 | 2018-06-14 | Kompozycje i sposoby hamowania beta sekretazy |
| PL18817403.1T PL3638278T3 (pl) | 2017-06-15 | 2018-06-15 | Kompozycje neuroprotekcyjne i ich zastosowanie |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18817403.1T PL3638278T3 (pl) | 2017-06-15 | 2018-06-15 | Kompozycje neuroprotekcyjne i ich zastosowanie |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11458117B2 (pl) |
| EP (2) | EP3638277B1 (pl) |
| JP (2) | JP7209645B2 (pl) |
| KR (2) | KR20190134809A (pl) |
| CA (2) | CA3063751C (pl) |
| ES (1) | ES3005508T3 (pl) |
| FI (1) | FI3638277T3 (pl) |
| PL (2) | PL3638277T3 (pl) |
| WO (2) | WO2018232063A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7209645B2 (ja) * | 2017-06-15 | 2023-01-20 | サミ－サビンサ グループ リミテッド | βセクレターゼの阻害のための組成物および方法 |
| US12465585B2 (en) * | 2018-06-15 | 2025-11-11 | Sami-Sabinsa Group Limited | Compositions for the management of seizure induced neurotoxicity |
| CN110115712A (zh) * | 2019-07-04 | 2019-08-13 | 兰州大学 | 一种同时激活氧化磷酸化通路和抑制糖酵解途径的激活剂及其应用 |
| KR20220049575A (ko) * | 2019-08-26 | 2022-04-21 | 새미-사빈사 그룹 리미티드 | 식물 활성물질 및 이의 오염 방지 효과 |
| CN114246879B (zh) * | 2021-12-30 | 2023-10-27 | 沈阳兴齐眼药股份有限公司 | 木蝴蝶苷b在制备用于预防、控制和/或治疗眼部疾病药物中的用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2703698C (en) * | 2002-04-30 | 2016-11-22 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| US8945518B2 (en) * | 2002-04-30 | 2015-02-03 | Unigen, Inc. | Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions |
| US8034387B2 (en) * | 2002-04-30 | 2011-10-11 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
| KR20070030160A (ko) * | 2003-09-02 | 2007-03-15 | 유니젠 파아마슈티컬스,인크. | 인지기능 감퇴 및 노화 관련 기억 장애의 예방 및 치료에사용하기 위한 프리-비-링 플라보노이드 및 플라반의혼합물의 제형 |
| JP2009527461A (ja) * | 2006-01-09 | 2009-07-30 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | 胃腸毒性、関連する症状及び潰瘍の処置のための天然作用物質 |
| JP2009527541A (ja) * | 2006-02-21 | 2009-07-30 | カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ | 腸管αグルコシダーゼ阻害剤ならびにその単離方法およびその使用 |
| WO2007112288A2 (en) * | 2006-03-23 | 2007-10-04 | Mount Sinai School Of Medicine | Cardiovascular composition and use the same for the treatment of alzheimers disease |
| KR20080008929A (ko) * | 2006-11-20 | 2008-01-24 | 대한민국(관리부서 식품의약품 안전청장) | 오록실린 ａ를 함유하는 인지 기능 장애 관련 질환의 예방및 개선용 건강기능식품 |
| BR112015004418A2 (pt) * | 2012-08-29 | 2017-07-04 | Mannkind Corp | composição de pó seco inalável, sistema de liberação de fármaco, processo para formar uma partícula e kit. |
| AU2017356883B2 (en) * | 2016-11-11 | 2023-03-30 | Sami Labs Limited | Composition containing Oroxylin a and method of extraction thereof |
| JP7209645B2 (ja) * | 2017-06-15 | 2023-01-20 | サミ－サビンサ グループ リミテッド | βセクレターゼの阻害のための組成物および方法 |
-
2018
- 2018-06-14 JP JP2019568236A patent/JP7209645B2/ja active Active
- 2018-06-14 EP EP18816475.0A patent/EP3638277B1/en active Active
- 2018-06-14 WO PCT/US2018/037454 patent/WO2018232063A1/en not_active Ceased
- 2018-06-14 FI FIEP18816475.0T patent/FI3638277T3/fi active
- 2018-06-14 ES ES18816475T patent/ES3005508T3/es active Active
- 2018-06-14 KR KR1020197034396A patent/KR20190134809A/ko not_active Ceased
- 2018-06-14 CA CA3063751A patent/CA3063751C/en active Active
- 2018-06-14 US US16/008,219 patent/US11458117B2/en active Active
- 2018-06-14 PL PL18816475.0T patent/PL3638277T3/pl unknown
- 2018-06-15 US US16/009,490 patent/US10894029B2/en active Active
- 2018-06-15 JP JP2019569247A patent/JP6796217B2/ja active Active
- 2018-06-15 WO PCT/US2018/037724 patent/WO2018232224A1/en not_active Ceased
- 2018-06-15 PL PL18817403.1T patent/PL3638278T3/pl unknown
- 2018-06-15 KR KR1020197033007A patent/KR20190131589A/ko not_active Ceased
- 2018-06-15 CA CA3063757A patent/CA3063757C/en active Active
- 2018-06-15 EP EP18817403.1A patent/EP3638278B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3063751A1 (en) | 2018-12-20 |
| EP3638278A4 (en) | 2021-03-17 |
| CA3063757A1 (en) | 2018-12-20 |
| US20180360801A1 (en) | 2018-12-20 |
| EP3638278A1 (en) | 2020-04-22 |
| JP6796217B2 (ja) | 2020-12-02 |
| WO2018232224A1 (en) | 2018-12-20 |
| CA3063757C (en) | 2023-08-01 |
| KR20190134809A (ko) | 2019-12-04 |
| EP3638277A1 (en) | 2020-04-22 |
| JP7209645B2 (ja) | 2023-01-20 |
| EP3638277B1 (en) | 2024-10-09 |
| US10894029B2 (en) | 2021-01-19 |
| FI3638277T3 (fi) | 2025-01-10 |
| ES3005508T3 (en) | 2025-03-14 |
| US20180360800A1 (en) | 2018-12-20 |
| JP2020523372A (ja) | 2020-08-06 |
| US11458117B2 (en) | 2022-10-04 |
| EP3638278B1 (en) | 2022-05-11 |
| WO2018232063A1 (en) | 2018-12-20 |
| KR20190131589A (ko) | 2019-11-26 |
| CA3063751C (en) | 2023-01-03 |
| JP2020523342A (ja) | 2020-08-06 |
| PL3638278T3 (pl) | 2022-10-03 |
| EP3638277A4 (en) | 2021-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277079B1 (en) | Carnitine preparations and methods of use | |
| IL280134A (en) | Anti-CD112R preparations and methods | |
| SG11202103571XA (en) | Compositions and methods for immunotherapy | |
| IL259576A (en) | Preparations and methods for immuno-oncology | |
| GB201718801D0 (en) | Compositions and methods for inhibiting factor D | |
| GB201807325D0 (en) | Compositions and methods | |
| SG11202101777VA (en) | Methods and compositions for the modification of plants | |
| LT3189074T (lt) | Kompozicijos ir būdai skirti uždegimo gydymui ir prevencijai | |
| IL274524A (en) | Preparations and methods for aquaculture | |
| SG11202104448WA (en) | Compositions and methods | |
| IL271256A (en) | Preparations and methods for the treatment of teopathy | |
| PL3638277T3 (pl) | Kompozycje i sposoby hamowania beta sekretazy | |
| SG11202106053SA (en) | Compositions and methods for immunotherapy | |
| ZA202004532B (en) | Compositions for the management of hyperglycemia and related conditions | |
| ZA202001320B (en) | Compounds and compositions for ire1 inhibition | |
| SG11202003261PA (en) | Sanitizing compositions and methods for making and using same | |
| IL282824A (en) | Preparations and methods for treating transient biofilms | |
| SG10201913497XA (en) | Biopharmaceutical compositions and related methods | |
| ZA202004533B (en) | Skin-brightening compositions and methods | |
| IL281875A (en) | Composition of suspension and solution | |
| GB201817444D0 (en) | Methods and compositions | |
| IL277058A (en) | Compositions and methods for inhibiting expression of GYS2 | |
| AU2018301500A1 (en) | Methods and compositions for treating inflammation | |
| IL258222A (en) | Compositions and methods for inhibiting beta-lactamase | |
| GB201819987D0 (en) | Methods and compositions |